Welcome to our dedicated page for Nuveen S&P 500 Dynamic Overwrite Fund SEC filings (Ticker: SPXX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Nuveen S&P 500 Dynamic Overwrite Fund (NYSE: SPXX) SEC filings page on Stock Titan is intended to organize the fund’s regulatory documents in one place and pair them with AI-generated explanations. As a diversified closed-end management investment company, SPXX is subject to U.S. securities regulation and files reports and registration materials with the Securities and Exchange Commission.
For a fund like SPXX, key filings typically include registration statements describing its investment objective and strategy, which in this case involve seeking attractive total returns with less volatility than the S&P 500 Index by investing in a U.S. equity portfolio that aims to substantially replicate the price movements of the S&P 500 Index and selling call options on a portion of the portfolio. When corporate actions are proposed, such as the announced plan to merge Nuveen S&P 500 Buy-Write Income Fund (BXMX) and Nuveen Dow 30℠ Dynamic Overwrite Fund (DIAX) into SPXX, the funds expect to file solicitation materials in the form of a proxy statement and/or a joint proxy statement/prospectus included in a registration statement on Form N-14.
On Stock Titan, when such documents are available, AI tools can summarize lengthy proxy statements, registration statements, and other reports to highlight the sections that describe SPXX’s investment policies, option-writing strategy, risk factors, and details of any proposed mergers. Investors interested in governance and shareholder rights can review proxy materials that discuss Board elections, shareholder meeting procedures, and rules for submitting shareholder proposals, as described in the Business Wire communication.
Although no specific SPXX SEC filings are listed in the provided data, this page is designed to surface those filings as they appear on the SEC’s EDGAR system and to present them with plain-language explanations. That can help investors interpret complex documents related to SPXX’s structure, strategy, and any significant corporate actions.
Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX), Nuveen S&P 500 Buy-Write Income Fund (BXMX) and Nuveen S&P 500 Dynamic Overwrite Fund (SPXX) are asking shareholders to approve mergers that would combine DIAX and BXMX into SPXX, along with the related issuance of new SPXX common shares and the election of four Board members for each fund.
The Boards and Nuveen Fund Advisors cite potential benefits such as greater secondary-market liquidity, narrower discounts for the Target Funds, and lower net operating expenses from a larger combined asset base and lower fee schedule. Pro forma, the combined fund’s total expense ratio is estimated at 0.84%, below each individual fund’s recent levels.
The mergers are structured to qualify as tax-free reorganizations, so Target Fund shareholders are expected to recognize no gain or loss when they receive SPXX shares, except for cash paid in lieu of fractional shares. However, portfolio repositioning after the mergers would have produced about $96.7 million of net capital gains, or about $0.70 per pro forma share, if done on August 31, 2025, which would be taxable when distributed. The mergers are expected to become effective on or about February 23, 2026, if shareholders approve them at the January 29, 2026 meetings.